LRX712

First-in-human, Safety, Tolerability and Pharmacokinetics Study of LRX712 in Osteoarthritic Patients

Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA

A randomized, placebo controlled, subject and investigator blinded, first-in-human, single ascending dose study to evaluate the safety, tolerability, and pharmacokinetics after intra-articular injection of LRX712 into the knee of osteoarthritic patients.